The role of S1PR1 in the accumulation of tumor-specific Tregs was underpinned in studies with breast cancer patients, demonstrating that S1PR1-dependent decreased Treg levels in the bone marrow correlated with increased tumor antigen-specific Treg redistribution to the tumor. The gene discussed is S1PR1; the disease is breast carcinoma.